Josephine Mak

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

Mark G. Thompson, Jefferey L. Burgess, Allison L. Naleway et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 794 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Mark G. Thompson, Jefferey L. Burgess, Allison L. Naleway et al. · New England Journal of Medicine · 2021 · 525 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

Ashley Fowlkes, Sarang K. Yoon, Karen Lutrick et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 183 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17

Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024

Ruth Link‐Gelles, Allison Avrich Ciesla, Josephine Mak et al. · MMWR Morbidity and Mortality Weekly Report · 2024 · 167 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023

Joanna J. Regan, Danielle Moulia, Ruth Link‐Gelles et al. · MMWR Morbidity and Mortality Weekly Report · 2023 · 141 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17